BioNTech SE - ADR vs Gemini Space Station Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Gemini Space Station Inc trades at $4.02 (market cap $512.05M). The key difference: BioNTech SE - ADR is far larger — about 45.5× Gemini Space Station Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | GEMI | |
|---|---|---|
Market Cap | $23.31B | $512.05M |
Sector | Health | Technology |
52-Week High | $119.34 | $32.52 |
52-Week Low | $83.89 | $3.90 |
Enterprise Value | $6.60B | $502.04M |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →